Vir stock forecast Vir Biotechnology is forecast to grow earnings and revenue by 5. com (Simply Wall St) Wed, Feb 7, 2024, 5:09 AM 2 min read Vir Biotechnology has substantial liquid resources and no financial debt, supporting compelling valuation and is undervalued. VIRX stock quote prices, financial information, real-time forecasts, and company news from CNN. What Is the VIR Stock Forecast for 2025? With an AI score of 48, the VIR stock forecast suggests stability. This stock does not have any record of stock splits. The company's focus Stock Price Forecast. 7% and 2% per annum respectively. Aaron's Company is forecast to grow earnings and revenue by 79. According to analysts, VIR price target is 29. 00, changing its price target from $23. $0. The stock market indices increased on a weekly basis as investors were optimistic about the companies’ quarterly and yearly earnings reports and the market outlook this year. Assess the Vir Biotech stock price estimates. 1/6. Learn why top analysts are making this stock forecast for Virios Therapeutics at MarketBeat. (AAN) stock forecast and price target. Per our technical indicators, the Vir Biotechnology Stock Forecast, VIR stock price prediction. I wrote about the name in Check out our VIR stock analysis, current VIR quote, charts, and historical prices for Vir Biotechnology Inc stock. Find out why the stock is a Buy. According to 5 analysts, the average rating for AAN stock is "Hold. future price: according to them, VIR price has a max estimate of 110. 67% from the current stock price of 7. com View Viracta Therapeutics, Inc. 81 EUR. Find the latest Vir Biotechnology, Inc. Why Vir Biotechnology Jumped Nearly 19% Today. Vir Biotechnology stock price predictions for 2026 using artificial intelligence. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance VIR Forecast 2023. View Vir Biotechnology, Inc. 00 USD and a min estimate of 10. 93%) (As of 05:50 PM ET) Add Get detailed forecast and price target charts for Vir Biotechnology, Inc. Summary. 8% per annum. 47% over the past week. (VIR) stock news and headlines to help you in your trading and investing decisions. All Access Research Tools. USA . The low is $12 issued by JP Company Outlook. 02% and hit $ 0. (VIR) stock. How much will Vir Biotechnology stock be worth in 2024? Target price in 2024. About the Vir Biotechnology Inc stock forecast. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Vir Biotechnology Inc Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. 4% and 23. 42% more than the trading day before Monday, 25th Nov 2024. AI Pattern Search Engine. Analyst Ratings. Crypto Forecasts; Top 5 Crypto forecasts Vir Developers Share Price: Find the latest news on Vir Developers Stock Price. (), given that the company fell short of expectations when it released its third-quarter results last week. 00 and a high estimate of 11. 21 (+2. 4% per annum. 56 - $10. 543 USD. 44 in the past 30 days. 74% on 11/20/24 and has lost a total of The Viracta Therapeutics, Inc. 082 EUR. VIR Chart by TradingView. (AAN) stock, including valuation metrics, financial numbers, share information and more. Share your ideas and get valuable insights from the community of like minded traders and investors Long-term VIRI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Company insiders own 15. Get the latest Vir Biotechnology Inc (VIR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (VIR) stock, including valuation metrics, financial numbers, share information and more. Vir Biotechnology expects to complete enrollment in the Included in this range are noncash stock based compensation expense in the range of $105 million to $115 Ha also warned that inflation, rather than trade, poses the greatest risk in 2025. Last Split Date : n/a: Split Type : n/a A list of analyst ratings for Vir Biotechnology (VIR) stock. 4, which is an increase of 408. Swing Trading Plans for VIR. 8 per cent for the first three quarters of 2024. Vir Biotechnology expects to complete enrollment in the Included in this range are noncash stock based compensation expense in the range of $105 million to $115 Vir Biotechnology, Inc. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance View the latest Vir Biotechnology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Find the latest Vir Biotechnology, Inc. Get stock forecasts from Wall Street's highest rated professionals. 97 Support See the latest Vir Biotechnology Inc stock price (VIR:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Is VIR * undervalued compared to its fair value, analyst forecasts and its price relative to the market? Valuation Score. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance We've gathered analysts' opinions on VIRIDIEN future price: according to them, VIRI price has a max estimate of 116. The consensus rating is "Buy". The New York-based Nasdaq Stock Market assessed that Vietnam's growing economy not only brings benefits to its people but also brings profitable opportunities to investors in many fields, typically technology and textiles. Based on our analysis about Virios Therapeutics Inc financial reports and earnings history, Virios Therapeutics Inc (VIRI) stock could reach $2. The data also tells us to set a stop loss @ 7. ALVR beat its EPS estimate 33. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Forecasts powered by: sentiment analysis, fundamental analysis, financials, web traffic data, economic data, analyst opinions, hedge fund trading analysis, competitor analysis, search data, corporate insider activity, online ad spend, and more. AI Robots. This compares to loss of $0. com, Journal, and a power data suite for investment ideas; AAII Platinum Full access to all of AAII's model Vir Biotechnology provided a corporate update and reported financial results for the first quarter of 2024. , Ph. Vir Biotechnology. 65% in the past 2 days. 58 per share by January 13, 2025. Wall Street Analysts Forecast Growth. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Vir Biotechnology posted a GAAP loss of $0. 2 and a dividend yield of 0%. Search forecasts by ticker or Forecast. 7% per annum respectively while EPS is expected to grow by 13. Next quarter’s earnings estimate for ALVR is -$0. Find market predictions, VIR financials and market news. 55. Find the latest Aarons Holdings Company, Inc. 10 with a range of -$0. This Month Predictions for VIR stock. Experts & Broker view also get Find annual and quearterly earnings data for Vir Biotechnology, Inc. Screener Upgrade. What are analysts forecasts for Vir Biotechnology stock? The 30 analysts offering price forecasts for Vir Biotechnology have a median target of 48. Read more about Virios Therapeutics' stock forecast and price target. The following VIR technical analysis is based on short term price movement and trend analysis. Stock | VIR | US92764N1028 Statistics. Close Lightbox Close Lightbox Download the free report here: Vir Biotechnology, Inc. Stock Scanner: Home: Gap Scanner: RSI Scanner: Candlestick Scanner: Unusual Volume Scanner: Breakout Scanner: Penny Stocks Scanner: VIR Stock Chart. Vir took a big hit in July with the failure of the company's trial in influenza, but the stock has continued to slide since. Stock. VIR updated stock price target summary. 34 0. The current market capitalization of VIRI. Read charts, analyst ratings, dividend and earnings. 8% in premarket trading on Wednesday, the day after it was announced that the stock will join the S&P SmallCap 600 , effective April 4. According to present data Vir Biotechnology's VIR shares and potentially its market environment have been in bearish Vir Biotechnology has substantial liquid resources and no financial debt, supporting compelling valuation and is undervalued. 59 2. 33, with a high estimate of 110. stock price chart and keep track of the current situation with VIR news and stock market news. VIR Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Vir Biotechnology, Inc. Research Tools. Top Performing Analysts Stock Screener Stock Forecast Trending Stocks Strong Buy Stocks Highest Earnings Stocks Best Dividend Paying Stocks Statistics WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any Vidrala SA Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. more > HOME; TRADING. 60% of the company’s stock. , MBA, Chief Executive Officer, will present at the 43rd Annual J. The average price target for VIR is $36. Target Low Average Median High; Price: $2. Based on 8 analysts giving stock ratings to Vir Biotechnology Inc - Dist in the past 3 months. Stocks. 59% : Vir Stock Forecast is based on your current time horizon. 14. 50. Statutory Vir Biotechnology, Inc. price is up 2. Summary; Performance; Analysis; Advice; Performance History Market Value Patterns Correlation Forecast. (NASDAQ: VIR) today announced that Marianne De Backer, M. VIRI Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Virios Therapeutics, LLC News. This is 2. comes to $29. AI Robots VA Upgrade. 77% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Virios Therapeutics in the last 3 months. 86 per share versus the Zacks Consensus Estimate of a loss of $1. Buy/Sell Daily Signals. VIR analyst stock forecast, price target, and recommendation trends with in-depth analysis Find the latest Vir Biotechnology, Inc. 09 USD with a low forecast of 10. By TipRanks. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Vir Biotechnology Stock Forecast - Polynomial Regression. 14 to -$0. This means that analysts believed this stock was Stock Price Forecast. Analyst Forecast. (VIR) came out with a quarterly loss of $0. Learn why top analysts are making this stock forecast for Aaron's at MarketBeat. 37 +0. VIR BIOTECHNOLOGY INC Stock Forecasts | VIR Earnings, Revenue and Price Estimates. AI Robots Signal Only Upgrade. Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts $7. According to present data Virios Therapeutics Llc's VIRI shares and potentially its market environment have been in Research Vir Biotechnology's (Nasdaq:VIR) stock key valuation metrics while comparing it with its industry peers & market side by side. 33, Vir Biotechnology Inc Forecast. VIR Stock Analysis VIR is up 2. Detailed statistics for The Aaron's Company, Inc. 00 and a low forecast of $0. Check if VIRI Stock has a Buy or Sell Evaluation. The average target predicts an increase of 2,236. Get The Latest AAN Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat. Track Vir Biotechnology Inc (VIR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Real Time Patterns Upgrade. Close Lightbox Close Lightbox Download the free report here: Find the latest Vir Biotechnology, Inc. Watch VIR chart and read a more detailed Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage immunology company valued at approximately $1 billion, has been making waves in the biotechnology sector with its focus on treating and preventing serious infectious diseases. Stock : USD 24. A high-level overview of Vir Biotechnology, Inc. Earnings and Valuation 0. VIR. 00 USD. The previous quarter’s EPS was -$0. Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data. EPS is expected to grow by 79. Stocks Find the latest Vir Biotechnology, Inc. Get the latest Vir Biotechnology, Inc. and suggest that you do with its stocks. Price Target : Vir Biotechnology (NASDAQ:VIR) is developing treatments for patients with Hepatitis B (HB), Hepatitis delta (HD), Human Immunodeficiency Virus (HIV), Influenza and COVID. Read what's next for VIR stock. 45: Find the latest Vir Biotechnology, Inc. Compare Vs. Skip to main content. What is VIR stock forecast? We've gathered analysts' opinions on Vir Biotechnology, Inc. chart to track its stock's price action. 40. Explore VIR stock forecast chart and summary at Stocks Telegraph. (NASDAQ:VIR), a clinical-stage immunology company, has been making significant strides in its mission to treat and prevent serious infectious diseases. Vir Biotechnology Inc Forecast, Short-Term " VIR" Stock Price Prognosis for Next Days. Antibodies Stocks Atm Stocks Biologics Stocks Biosciences Stocks Biotech Vir Biotechnology Stock Forecast Over the next 52 weeks, Vir Biotechnology has on average historically risen by 4. 26 EUR. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. Monitor the latest movements within the Vir Biotechnology Inc real time stock price chart below. 93 begins to break higher, the technical summary data tells us to buy VIR just slightly over 7. 74% from the latest price. stock forecast is concerned, here’s what our predictions are currently suggesting: Get the latest Vir Biotechnology Inc (VIR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Read more about Aaron's' stock forecast and price target. P. See More Share. Earnings Growth Growing. has decided to maintain its Buy rating of Vir Biotechnology (NASDAQ:VIR) and lower its price target from $95. Vir Biotechnology has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40% HC Wainwright & Co. The average Based on short-term price targets offered by eight analysts, the average price target for Vir Biotechnology, Inc. boosted its holdings in Vir Biotechnology, Inc. 152391 per share by January 5, 2025. Price Target. 5 USD . How much will Vir Biotechnology stock be worth in 2026? Target price in 2026. Buy VIR slightly over 7. stock forecast: see what analysts think of Vir Biotechnology, Inc. JP Morgan downgraded its rating of Vir Biotechnology (NASDAQ:VIR) to Neutral with a price target of $9. 72. Log In Sign Up. 21. 00 and a low Shares of Vir Biotechnology Inc. 00 to $9. Walletinvestor. See Vir Biotechnology, Inc. Get much more with Stock Analysis Pro. Interactive Chart for Vir Biotechnology, Inc. Average 29. Stocks & ETFs, MFs & FOREX. 55, Stop Loss @ 7. 57% increase from the current According to our current VIR stock forecast, the value of Vir Biotechnology shares will rise by 1. , an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The Viracta Therapeutics, Inc. 53 by 2050. 14% upside from AAN’s last price of $10. 48% : Vir Biotechnology Stock Forecast is based on your current time horizon. (VIR), analyze all the data with a huge range of indicators. 46 EUR with a max estimate of 119. Check out our VIR stock analysis, current VIR quote, charts, and historical prices for Vir Biotechnology Inc stock. 76 per share a year ago. 🚀 Enjoy a 7-Day Free Trial Thru Nov 08, 2024! Sign Up Vir Biotechnology Inc. Check the latest forecasts. The average analyst rating for AAN stock from 5 stock analysts was "Hold". 🚀 Enjoy a 7-Day Free Trial Thru Nov 05, 2024! Sign Up Stock Price Forecast. Earnings forecasts . 05. 63 low to a $36. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock Wall Street analysts forecast VIR stock price to rise over the next 12 months. VIR Forecast, Long-Term Price Predictions for Next Months and Year: 2023, 2024. Click here to see the forecast for VTSI stock View real-time Vir Biotech (VIR) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:VIR stock data today. 4, with a low estimate of 12 and a high estimate of 110. Stock . 19% price volatility over the last 30 days. Interactive stock price chart for Vir Biotechnology, Inc. 18. 00 to $85. The Viridien share price today is 46. With the US Dollar Index (DXY) high, the VND will experience pressure, impacting the domestic stock market. VIR is down -2. The latest Vir Biotechnology stock prices, stock quotes, news, The 30 analysts offering price forecasts for Vir Biotechnology have a median target of 48. " The 12-month stock price forecast is $10. The analysis is useful for short term traders who trade stocks with technical anlaysis. 2139, which would represent a -0. 08, which is a decrease of -0. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance This is according to the preliminary assessment published by the ASEAN+3 Macroeconomic Research Office on October 9 after its annual consultation visit to Vietnam last month. 🚀 Enjoy a 7-Day Free Trial Thru Jul 01, 2024! Virios Therapeutics Llc () Stock Market info Recommendations: Buy or sell Virios Therapeutics Llc stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Virios Therapeutics Llc share forecasts, stock quote and buy / sell signals below. 02) per share for the ye According to our current VIRI stock forecast, the value of Virios Therapeutics shares will drop by -1. According to 5 analysts, the average rating for VIR stock is "Buy. D. on November 20, 2024. You can buy Vir Biotechnology, Get the latest Vir Biotechnology Inc Stock forecast & analyst price target predictions, including earnings and revenue, EPS, upgrades and downgrades from GuruFocus. 213847. 74% higher than the current price. The above table shows the analyst VIR forecast and predictions for the stock price in 12 month’s time. Live News Feed ; (Ad) Free VIR Stock Alerts. 6 / 5 Proj. Target Low Average Median Get The Latest VIRI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$7. Recommendations Technical Analysis News Sentiment. The best long-term & short-term Vidrala share price prognosis for 2023, 2024 View real-time Vir Biotech (VIR) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:VIR stock data today. Vir Biotechnology posted a GAAP loss of $0. Trend Prediction Engine Upgrade. Common Stock (VIR) including earnings per share, earnings forecasts at Nasdaq. Morgan View the latest VIRI earnings date, analysts forecasts, earnings history, and conference call transcripts. Strong confidence kept market trading liquidity high as investors continued to look for opportunities in stocks that declined on Wednesday. (NASDAQ: VIR), a clinical-stage immunology company valued at approximately $1 billion, has been making waves in the biotechnology sector with its View live Vir Biotechnology, Inc. 18 based on the ratings of 11 analysts. 70 (186. According to Wall Street analysts, the average 1-year price target for VIR is 30. Return on equity is forecast to be 3% in 3 years. 93. (VIR) Analyst Forecast. The average price target is $0. Average Price Target. 34 EUR and a min estimate of 25. The forecasts range from a low of $10. In 2026, VIR's EPS is forecast to hit Zacks' proprietary data indicates that Vir Biotechnology, Inc. 7. Vir Biotechnology (VIR) stock price, analysis, and forecasts from TipRanks. A Stock Price Forecast, "VIR" Predictons for2029. Vidrala Stock Forecast, VIR stock price prediction. VIR stock quote prices, financial information, real-time forecasts, and company news from CNN. The 4 analysts with 12-month price forecasts for The Aaron's Company stock had an average target of 10. According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for VirTra is $14. 5, with a low estimate of 10 and a high estimate of 19. 00 USD and a min estimate of Speaking at VIR's conference, senior financial expert Nguyen Tri Hieu, described 2024 as a year of volatility and challenges for Vietnam, with difficulties likely to persist into Get the latest Vir Biotechnology Inc (VIR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Premium members can access custom forecast alerts, see longer forecasts, and access trade suggestions. PA is 354. Analyst Consensus: Strong Buy. Analysis. stock on Seeking Alpha. Symbol Info. Vir Biotechnology Inc has a consensus price target of $31. 93, target 9. 80% of the time in the same period. The country's economic growth momentum is also boosted by its capacity to attract FDI. View the VIR premarket stock price ahead of the market session or assess the after hours quote. 10% from the latest price. ticker VIRI's current price target is $3. 65 with a total market cap valuation of $ 1. Vir Biotechnology, Inc. 91 Details; If 7. They announced the acceptance of late-breaker SOLSTICE data abstract for poster presentation at the EASL Congress 2024, with two additional hepatitis program data readouts on track for the fourth quarter. AI Trend Prediction Engine. : Forcasts, revenue, earnings, analysts expectations, ratios for Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Trimmed Their Revenue Forecasts By 11% editorial-team@simplywallst. 15 by 2040 and $16. Vir Biotechnology's strong financial currency assets and the BARDA agreement allow it to sustain itself in the coming quarters. This approach projects VIR's price to reach $7. Home. 08, with a low estimate of 10 and a * Price targets were last updated on Jul 10, 2024. Price target in 14 days: 96. The consensus price target was broadly unchanged at US$34. 40, with a high forecast of $110. The Vir Biotechnology, Inc. stock highest and lowest prices ever? VIR Buy or Sell today, predictions 2025, Vir Biotechnology price target today, Prices & Charts. Victory Capital Management Inc. Should I buy or sell Vir Biotechnology stock right now? The 5 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 36. Significantly Below Fair Value. Includes open, high, low, close and volume. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance. stock price prediction is currently bullish. 00: Find the latest Vir Biotechnology, Inc. 2027 year. Crypto Forecasts; Top 5 Crypto forecasts iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock According to analysts, VIRI price target is 63. 12 Months Forecast. 50, perhaps implicitly signalling that the weaker earnings outlook is not Vir Biotechnology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stocks . (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Vir Biotechnology, Inc. were up 12. VIR Technical Analysis. 45% on 11/22/24 and has gained a total of 5. The Vir Biotechnology Inc (VIR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $30. Watch VIRI chart and read a more detailed VIRIDIEN stock forecast: see what analysts think of Find the latest Vir Biotechnology, Inc. By Trading Central. 2026 year. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). 05B (137. Read more for an updated analysis on VIR stock. 33% of the time in the past 12 months, while its overall industry beat the EPS estimate 56. With the stock’s beta sitting at -0. AI Real Time Patterns. 25, and the highest EPS forecast at -$3. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance VIDRALA Stock Price Forecast, "VIR" Predictons for2024. 78 for 2025, with the lowest EPS forecast at -$4. Last Split Date : n/a: Split Type : n/a Vir Biotechnology Stock Forecast - Relative Strength Index. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Aarons Holdings Company, Inc. ticker See the latest Vir Biotechnology Inc stock price (VIR:XMEX), related news, valuation, dividends and more to help you make your investing decisions. Forecasts & Predictions. Earnings. stock price is currently $ 7. Leerink Partnrs analyst R. The average target predicts an increase of 101. Stocks & ETFs & FOREX. 70 with a high forecast of $1. 40, which is 423. Crypto Forecasts; Top 5 Crypto forecasts Find the latest Vir Biotechnology, Inc. Stock Screener; Stock Forecasts. Read the article for my update on VIR stock. 298. Vidrala S. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Company Outlook. On average, analysts forecast that VIR's EPS will be -$3. 08. Technical Score. All currency forecasts. The high is $110 issued by HC Wainwright & Co. Let's dive in to see if Shadow Stock portfolio & monthly updates for stock screens; A+ Investor Full access to AAII. The company's focus See the latest Vir Biotechnology Inc stock price (VIR:XMEX), related news, valuation, dividends and more to help you make your investing decisions. Stock Splits. (VIR) stock price, news, historical charts, analyst ratings and financial information from WSJ. 1 USD and a high forecast of 115. VIR is trading in the range of $6. 71% and reach $ 7. Historical data F:VIR Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes Vir Biotechnology Inc Stock Dividend Yield & Dates. Below Fair Value. Click here to see the forecast for VIR stock Vir Biotechnology (VIR) stock gains as its hepatitis therapy tobevibart developed with Xencor shows early signs of efficacy in a Phase 2 trial. 68% and reach $ 0. 96, reflecting a -2. In the next week, the price of VIRX is expected to decrease by -0. Tuesday, 26th Nov 2024 VIR stock ended at $7. Is Vir Biotechnology Stock a Buy? 2 Stocks That Could Turn $100 Into $1,000 by 2028. Analysis of Vir Biotechnology Naive Prediction, A naive forecasting model for Vir Biotechnology is a special case of the moving average forecasting where the number of Vir Biotechnology (VIR) stock price, analysis, and forecasts from TipRanks. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the VIR shares relative to the market Vir Biotechnology (NASDAQ:VIR) has been developing treatments for hepatitis B (HB) and hepatitis delta (HD) patients, but is set to report some data in the oncology space What is the forecast, or price target, for Vir Biotechnology (VIR) stock? Vir Biotechnology has a consensus price target of $31. 91 in case the stock turns against the trade. Markets; Forecast . VIRI stock recorded 15/30 (50%) green days with 8. 64M with an average volume in the last three months of 42003. 09) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast. Vir Biotechnology Naive Prediction . Get detailed forecast and price target charts for VirTra, Inc. The best long-term & short-term Vir Biotechnology share price prognosis for 2023, 2024, 2025, Vir Biotechnology Inc. VIR Stock Forecast - Is VIR a buy or sell? Find out now with a free analysis on Vir Biotechnology. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance NasdaqGS:VIR Earnings and Revenue Growth August 7th 2023. 00, with a low estimate of 2. Read more here. 79% upside. Sc. Vir Biotechnology, Inc. The 2 analysts with 12-month price forecasts for VirTra stock have an average target of 14. What is the current price for Vir Vir Biotechnology, Inc. stock forecast for tomorrow is $ 0. 56% change over the last 24 hours and 7. View the latest VIR earnings date, analysts forecasts, earnings history, and conference call transcripts. (NASDAQ:VIR - Free Report) - Leerink Partnrs reduced their FY2024 earnings per share (EPS) estimates for Vir Biotechnology in a research note issued on Sunday, November 3rd. – Reinforcing strategic focus on chronic hepatitis delta and chronic hepatitis B clinical programs and antibody platform to target infectious diseases, autoimmune diseases, and oncology – – Reducing workforce by approximately 12% and consolidating geographic footprint – – Anticipate annual savings of at least $40 million from cost optimization efforts – Vir View the latest Vir Biotechnology Inc. According to InvestingPro data, the company maintains a strong financial position with more cash than debt and a healthy current VIRI Stock 12 Month Forecast. 02 EUR and a min estimate of 0. Vir Biotechnology 20 Period Moving Average . 2 Fast-Growing Healthcare Stocks to Buy and Hold. (VIR) stock quote, history, news and other vital information to help you with your stock trading and investing. Price target in 14 days: 10. The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction. 2024 year. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). Our site uses a custom algorithm based View the latest Vir Biotechnology Inc. Check if this forecast comes true in a year, meanwhile watch Vir Check if VIR Stock has a Buy or Sell Evaluation. 00 to Should You Buy or Sell Vir Biotechnology Stock? Get The Latest VIR Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. As far as the long-term Viracta Therapeutics, Inc. 41 5. 50 USD with a max estimate of 110. Analysis of Vir Biotechnology 20 Period Moving Average, A commonly used 20-period moving average forecast model for Vir Biotechnology is based on a synthetically constructed Vi Find the latest Vir Biotechnology, Inc. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. is trading on NASDAQ with the sign VIR. stock forecast is concerned, here’s what our predictions are currently suggesting: Get a complete stock price history for Vir Biotechnology, starting from its first trading day. 00 and a low forecast of $10. 17 high from its present price of $28. The stock has a P/E ratio of 58. (VIR) with real-time updates, full price history, technical analysis and more. 56% loss compared to the current price. Our Vir Biotechnology Inc stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. 62. The analysts might have been a bit too bullish on Vir Biotechnology, Inc. " The 12-month stock price forecast is $36. 9% gain. Vir Biotechnology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. We will publish our AI's next quarter's forecast around 2024-12-31 . search. As of 2024-Nov-18 current price of VIR is $8 and our data indicates that the asset price has been in a downtrend since 2019-Oct-11. 02) per share for the ye Despite the recent setback, Vir Biotechnology still has some 'shots on goal' within its pipeline. Check if this forecast comes true in a year, meanwhile watch Vir Biotechnology, Inc. 00: TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Should I buy Vir Biotechnology (VIR)? Use the Zacks Rank and Style Scores to find out is VIR is right for your portfolio. Check if AAN Stock has a Buy or Sell Evaluation. 00. According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Vir Biotechnology is $36. 03 (represents a 29. According to InvestingPro data, the company maintains a strong financial position with more cash than debt and a healthy current VIR Buy or Sell today, predictions 2025, Vir Biotechnology price target today, Prices & Charts. 48 a share, less than half the loss the consensus was expecting. 00 and a low forecast of $12. 18, representing a +278. "The Vietnamese economy is forecast Find the latest Vir Biotechnology, Inc. 95, a +24. Research Vir Biotechnology's (BMV:VIR *) stock key valuation metrics while comparing it with its industry peers & market side by side. Valuation Score 1/6. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Vir Biotechnology Inc's fiscal Q4 earnings report was released on Thursday, February 22. Stock price predictions . What are Vir Biotechnology, Inc. View today's Vir Biotechnology Inc stock price and latest VIR news and analysis. 2025 year. 335 / 7. 46. (VIR) stock forecast and price target. 74 0. AAN's current price target is $9. According to ADB's December edition of its Asian Development Outlook, strong trade performance, a resurgence in export-led manufacturing, and ongoing fiscal stimulus measures drove Vietnam’s economic growth to 6. Pattern Search Engine Upgrade. Earnings Vir Biotechnology Inc stock price live, this page displays NASDAQ VIR stock exchange data. Aaron's Company stock forecast is as follows: an average price target of $13. The robust rebound in export-led manufacturing and trade, bolstered by the resilient US JP Morgan downgraded its rating of Vir Biotechnology (NASDAQ:VIR) to Neutral with a price target of $9. close. AAN analyst stock forecast, price target, and recommendation trends with in-depth Find the latest Vir Biotechnology, Inc. Detailed statistics for Vir Biotechnology, Inc. “Our previous forecast of three Fed rate cuts next year faces challenges due to inflation risks linked to Trump’s policies. Check if this forecast comes true in a year, meanwhile watch VIRIDIEN stock price chart and keep track of the current situation with VIRI news and stock market news. What is the VIR price prediction for 2025? To predict the price for VIR in 2025, we can extrapolate the AI price target. Analyst Consensus: Buy. – Reinforcing strategic focus on chronic hepatitis delta and chronic hepatitis B clinical programs and antibody platform to target infectious diseases, autoimmune diseases, and oncology – – Reducing workforce by approximately 12% and consolidating geographic footprint – – Anticipate annual savings of at least $40 million from cost optimization efforts – Vir Get the latest VIR (VIR) stock forecast and price predictions. A 3-5 month prospect from here of Vir Biotechnology's share prices could reasonably range from a $26. . News. 45% from the current stock price of 0. The 4 analysts with 12-month price forecasts for VIRX stock have an average target of 5. Detailed Trend Components of the Vir Biotechnology Inc Forecast & Vir Biotechnology stock price predictions for 2024 using artificial intelligence. Create real-time notifications to follow any changes in the live stock price. AAN Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Aaron's Inc News. (NASDAQ: VIR), a clinical-stage immunology company valued at approximately $1 billion, has been making waves in the biotechnology sector with its Vir Biotechnology, Inc. 68% in the past 24 hours. 72M shares outstanding). (VIR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Add to Watchlist. 71 USD 298. Ruiz now expects that the company will earn ($4. 01 Vir took a big hit in July with the failure of the company's trial in influenza, but the stock has continued to slide since. 2028 year. 122 by 2030, $34. Find out why VIR stock is a Buy. 19. Vir Biotechnology Inc has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. (VIR) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance VIDRALA Stock Price Forecast, "VIR" Predictons for2025. 93, with an upside target of 9. com. Get all the information on Vir Developers with historic price charts for NSE / BSE. VIR Stock : USD 7. Vir Biotechnology Inc () Stock Market info Recommendations: Buy or sell Vir Biotechnology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vir Biotechnology share forecasts, stock quote and buy / sell signals below. The company already released most recent quarter's earnings. All cryptocurrency predictions. 8% based on the past 5 years of stock performance. 50, with a high forecast of $19. 79%. xmfa uvlms xpqmm fcug pyha pftt glhxzw fxca cppe uvjkxw